Patient info Open main menu

APREPITANT ZENTIVA 125 MG / 80 MG HARD CAPSULES - patient leaflet, side effects, dosage

Contains active substance :

ATC code:

Dostupné balení:

Patient leaflet - APREPITANT ZENTIVA 125 MG / 80 MG HARD CAPSULES

i9NINHVMluepodui|


610Z/Z ueqj jejei jou peiueuiaidui! eq ||im h

70s aiuapiAa jadtuoj_ Diop a/qoijM ai/j;o iqfyj ai/j uo paiupd 3pm XIJJDUJ D)DQ

:dX3

:dX3 :on qojeg :NS

:on qDieg

Od

UOIJtJZIItJUdS UOIJtJZIItJUdS

tnoqiiM sjepjQ sjepjQ


WdZEWl 0Z0Z/Z/9 I jpd'as Z+IXnVM CD DWSZl OS INVIlddddV xoa 6Z0610S901


1065019079_BO­X_APREPITANT80_125MG_CD­_WAL1XH2_GB.pdf 3 6/2/2020 1:37:38 PM

Z0NTIVA

PM CODE:

PM TYPE:

PRODUCT NAME:

SAP ID / GMID:

AW VERSION:

CREATION DATE:

AW BY:

SUPPLIER:

1065019079

Box

APREPITANT 80;125MG; CD WAL1X1+2

718149

V1

02.06.2020

RV

Pharmaten

n o

Ai Hl

n c Hl Wl

o u

? A*

w Lz_

o n

S? E

FORMAT SIZE (wxhxl):

FOIL (wxthickness):

LAETUS (pharma code):

FONT + MIN. SIZE:

LOOK CODE:

MATERIAL TYPE (TS):

BRAILLE TEXT:

100 × 24 × 145 mm

N/A

N/A

Helvetica Neue LT Std 7 pt

N/A

N/A

aprepitant

#125 mg/#80 mg

L J

  • PMS 287 C PMS 7528 C PMS 568 C PMS 339 C PMS 2727 C

TECHNICAL COLOURS

VARNISH FREE

S IS

  • KEYLINE BRAILLE

----------------- REASON FOR CHANGE---------------- Correction to the Braille text.

Space is required bewteen the number and the units ‚mg‘ in the braille text.

This needs to be implemented in the next production run.


1065019079_BO­X_APREPITANT80_125MG_CD­_WAL1X1+2_GB.ai

Page 3 of 3


i |aj_66Z‘Z6 'PM “fr8Z BAaa|s 96EZZ8Z poo jajeuiJELid

i |aj_66Z‘Z6 'PM “fr8Z BAsa|s Z6EZZ8Z poo ua|EUiJBL|d

1065018541_PO­ACH_APREPITAN­T80-125MG_CAP_BL3­_M24_GB_outl.pdf 2 12/17/2019 10:20:30 AM

90 mm

* 10mm <


290 mm

90 mm –


Read the package leaflet before use. Oral use.

See enclosed leaflet for additional information about how to take aprepitant.

WHEN and HOW to take aprepitant

Your doctor has prescribed aprepitant, an anti-emetic, to help prevent nausea and vomiting associated with chemotherapy.

Aprepitant 125 mg/80 mg hard capsules

HOW:

Aprepitant is taken just once a day for 3 consecutive days.

Aprepitant capsules can be taken with or without food.

Do not remove all capusles at one time.

To remove, push capsules through from this side.

Start of Therapy

WHEN:

Take one aprepitant 125 mg capsule by mouth 1-hour BEFORE you start your chemotherapy treatment.

Day 1 – Aprepitant 125 mg hard capsule

WHEN:

Take one aprepitant 80 mg capsule each morning on the next two days.

Day 2 – Aprepitant 80 mg hard capsule

Day 3 – Aprepitant 80 mg hard capsule

Aprepitant 80 mg capsule

As nausea and vomiting may occur in the days following your chemotherapy, it is important that you take aprepitant for 3 consecutive days as prescribed by your doctor.

KEEP OUT OF THE SIGHT AND REACH OF CHILDREN.

Store in the original package in order to protect from moisture.

PL 17780/0824

Zentiva Pharma UK Limited

12 New Fetter Lane

London EC4A 1JP

UK



t


E E

CT*

20,75 mm




CD


Q)

—L ND UI 5 io i 3



Aprepitant Zentiva 125 mg/80 mg hard capsules


aprepitant

Each 125 mg capsule contains 125 mg of aprepitant.

Each 80 mg capsule contains 80 mg of aprepitant. Contains sucrose and sodium


Aprepitant 125 mg/80 mg hard capsules 3-day treatment pack containing: 1 × 125 mg hard capsule and 2 × 80 mg hard capsule


Z0NTIVA